These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 14337854)

  • 1. [STUDIES ON THE CONTROLLABILITY OF FAT-CLEARANCE INSUFFICIENCY].
    ZELLER W; SCHOEN H; GRIMM B
    Med Klin; 1964 Sep; 59():1457-9. PubMed ID: 14337854
    [No Abstract]   [Full Text] [Related]  

  • 2. [RESEARCH ON THE INFLUENCE OF NICOTINIC ACID ON SERUM LIPID FRACTIONS].
    CALI G; PIETROPAOLO C; FIORENTINO E; AURITI R
    Prog Med (Napoli); 1964 Nov; 20():688-702. PubMed ID: 14313382
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE SIGNIFICANCE OF INSUFFICIENT CLEARANCE IN ATHEROGENESIS].
    SCHOEN H
    Munch Med Wochenschr; 1963 Dec; 105():2473-8. PubMed ID: 14133657
    [No Abstract]   [Full Text] [Related]  

  • 4. Nicotinic acid levels as an index of aluminum nicotinate activity in the treatment of hyperlipemia.
    HOLLOMAN JL; DAVIS CC; LEEPER LC
    J Am Geriatr Soc; 1962 Oct; 10():903-5. PubMed ID: 13961366
    [No Abstract]   [Full Text] [Related]  

  • 5. [PROLONGED TREATMENT WITH LARGE DOSES OF NICOTINIC ACID IN CORONARY ARTERIOSCLEROSIS].
    ILIESCU M; DOMOCOS G; IACOBINI P; CONSTANTINESCU S; ILIESCU CC
    Med Interna (Bucur); 1964 Mar; 16():301-10. PubMed ID: 14147064
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral nicotinic acid for hyperlipemia with emphasis on side effects.
    BELLE M; HALPERN MM
    Am J Cardiol; 1958 Oct; 2(4):449-52. PubMed ID: 13582888
    [No Abstract]   [Full Text] [Related]  

  • 7. [STUDIES ON THE TREATMENT OF ENDOGENOUS HYPERLIPOPROTEINEMIA WITH BETA-PYRIDYL-CARBINOL].
    SCHOEN H; ZELLER W; HENNING N
    Klin Wochenschr; 1963 Nov; 41():1108-9. PubMed ID: 14109876
    [No Abstract]   [Full Text] [Related]  

  • 8. [7-(3-(METHYL-OXYETHYLAMINE)-2-OXYPROPYL)-1, 3-DIMETHYL-XANTHINE NICOTINATE IN CHRONIC OBLITERATING ANGIOPATHIES].
    FERNANDEZBLANCO E; DEFERNANDEZBLANCO JF; AGUSTINARZENO J
    Sem Med; 1963 Nov; 123():1733-40. PubMed ID: 14110181
    [No Abstract]   [Full Text] [Related]  

  • 9. [STUDIES ON THE INFLUENCING OF FAT CLEARANCE IN VIVO].
    SCHOEN H; NEUMANN J
    Dtsch Med J; 1964 Feb; 15():98-101. PubMed ID: 14153957
    [No Abstract]   [Full Text] [Related]  

  • 10. [Administration of nicotinic acid in vascular diseases].
    TURCHETTI A
    Riforma Med; 1952 Jul; 66(27):729-31. PubMed ID: 12994578
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of a new nicotinic acid derivative (Bradilan) with special reference to its tolerability].
    PORTELLA A; SCARDINO R
    Rass Int Clin Ter; 1963 Apr; 43():433-40. PubMed ID: 13972344
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacologic agents and lipid metabolism.
    PARSONS WB
    Geriatrics; 1963 Jan; 18():31-8. PubMed ID: 13941610
    [No Abstract]   [Full Text] [Related]  

  • 13. [CURRENT THERAPY OF PERIPHERAL VASCULAR DISEASES].
    SIVORI A; RODRIGUEZNIETO AJ
    Dia Med; 1964 Mar; 36():152-3. PubMed ID: 14140893
    [No Abstract]   [Full Text] [Related]  

  • 14. Biosynthesis of sterols and fatty acids as affected by nicotinic acid and related compounds.
    Hardy RW; Gaylor JL; Baumann CA
    J Nutr; 1960 Jun; 71(2):159-67. PubMed ID: 14399771
    [No Abstract]   [Full Text] [Related]  

  • 15. Nicotinic acid and cholesterol metabolism.
    ALTSCHUL R
    GP; 1960 Jan; 21():115-8. PubMed ID: 13792995
    [No Abstract]   [Full Text] [Related]  

  • 16. [VASPERDIL IN THE TREATMENT OF PERIPHERAL VASCULAR DISEASES].
    KOWALSKA M
    Ther Umsch; 1964 Aug; 21():310-1. PubMed ID: 14299958
    [No Abstract]   [Full Text] [Related]  

  • 17. [Our experience with tetranicotinoyl-fructose in the treatment of peripheral vascular diseases].
    GUERRA G
    Riforma Med; 1962 Sep; 76():966-70. PubMed ID: 13951107
    [No Abstract]   [Full Text] [Related]  

  • 18. [RELATIONS BETWEEN THE METABOLISM OF CHOLESTEROL AND CARBOHYDRATES. II. ANTAGONISM OF NICOTINIC ACID AND D- THYROXINE IN EUTHYROID RATS].
    NAVA-RIVERA A; BERNAL-DIAZ L; AVENDANO-OLVERA M
    Bol Inst Estud Med Biol Univ Nac Auton Mex; 1964 Dec; 22():415-21. PubMed ID: 14247452
    [No Abstract]   [Full Text] [Related]  

  • 19. INFLUENCE OF NICOTINIC, PICOLINIC AND PYRIDINE-3-SULFONIC ACIDS ON CHOLESTEROL METABOLISM IN THE RAT.
    Kritchevsky D; Tepper SA
    J Nutr; 1964 Jan; 82(1):157-61. PubMed ID: 14110935
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the distribution and storage of thiamine and nicotinic acid introduced into the organism].
    RYBINA AO; LAKHNO IuV
    Ukr Biokhim Zh; 1961; 33():46-56. PubMed ID: 13745021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.